Abstract
Purpose
The aim of this study was to clarify the early magnetic resonance imaging (MRI) findings of progressive multifocal leukoencephalopathy (PML) and to evaluate the relations of the clinical course and serial MRI findings in patients with acquired immunodeficiency syndrome (AIDS)-related PML treated with highly active antiretroviral therapy (HAART).
Materials and methods
The clinical course and serial MRI findings in five patients with AIDS-related PML who were treated with HAART are described.
Results
Although all five patients were serologically naive to the therapy and alive at the end of the observation period, the lesions showed rapid extension on MRI for up to 3 months after the start of the therapy, and clinical symptoms progressed rapidly for a month after the start of the therapy. Newer margins in spreading lesions showed a diffuse pale hyperintensity and/or many discrete hyperintense dots on T2-weighted images
Conclusion
Early PML lesions may show a characteristic appearance on T2-weighted images. We should be aware of the progression of AIDS-related PML even under serologically effective HAART.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berger JR, Kaszovitz B, Post MJ, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Intern Med 1987;107:78–87.
Skiest DJ. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis 2002;34:103–115.
Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, et al. HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998. Neurology 2001;56:257–260.
Von Giesen HJ, Neuen-Jacob E, Dorries K, Jablonowski H, Roick H, Arendt G. Diagnostic criteria and clinical procedures in HIV-1 associated progressive multifocal leukoencephalopathy. J Neurol Sci 1997;147:63–72.
Marra CM, Rajicic N, Barker DE, Cohen BA, Clifford D, Donovan Post MJ, et al. A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 2002;16:1791–1797.
Garvey L, Thomson EC, Taylor GP. Progressive multifocal leukoencephalopathy: prolonged survival in patients treated with protease inhibitors and cidofovir: a case series. AIDS 2006;20:791–793.
De Luca A, Giancola ML, Ammassari A, Grisetti S, Cingolani A, Larussa D, et al. Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study. J Neurovirol 2001;7:364–368.
Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol 2006;60:162–173.
Thurnher MM, Post MJ, Rieger A, Kleibl-Popov C, Loewe C, Schindler E. Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol 2001;22:977–984.
Gray F, Chretien F, Vallat-Decouvelaere AV, Scaravilli F. The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 2003;62:429–440.
Wyen C, Hoffmann C, Schmeier N, Wohrmann A, Qurishi N, Rockstroh J, et al. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death. J Acquir Immune Defic Syndr 2004;37:1263–1268.
Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998;12:1149–1154.
Whiteman ML, Post MJ, Berger JR, Tate LG, Bell MD, Limonte LP. Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993;18:233–240.
Post MJ, Yiannoutsos C, Simpson D, Booss J, Clifford DB, Cohen B, et al. Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol 1999;20:1896–1906.
Gray F, editor. Opportunistic infections. Oxford, UK: Oxford University Press; 1993.
Johnston RT, Major ED. Progressive multifocal leukoencephalopathy. In: Lazzarini RA, editor. Myelin biology and disorders. San Diego: Elsevier Academic Press; 2004 p. 963–970.
Bergui M, Bradac GB, Oguz KK, Boghi A, Geda C, Gatti G, et al. Progressive multifocal leukoencephalopathy: diffusion weighted imaging and pathological correlations. Neuroradiology 2004;46:22–25.
Hoffmann C, Horst HA, Albrecht H, Schlote W. Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatment. J Neurol Neurosurg Psychiatry 2003;74:1142–1144.
Garrels K, Kucharczyk W, Wortzman G, Shandling M. Progressive multifocal leukoencephalopathy: clinical and MR response to treatment. AJNR Am J Neuroradiol 1996;17:597–600.
Kinoshita T, Ogawa T, Yoshida Y, Tamura H, Kado H, Okudera T. Curvilinear T1 hyperintense lesions representing cortical necrosis after cerebral infarction. Neuroradiology 2005;47:647–651.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Sakai, M., Inoue, Y., Aoki, S. et al. Follow-up magnetic resonance imaging findings in patients with progressive multifocal leukoencephalopathy: evaluation of long-term survivors under highly active antiretroviral therapy. Jap J Radiol 27, 69–77 (2009). https://doi.org/10.1007/s11604-008-0302-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-008-0302-3